A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom
Trial details
- Registry ID
- NCT04583995
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United KingdomNCT04583995 | Novavax | Phase 3 | Completed | 2022-03-29Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |